Do Cardioselective β-Adrenoceptor Antagonists Reduce Mortality in Diabetic Patients with Congestive Heart Failure?

Author： Subramanian Usha Kamalesh Masoor Temkit M'Hamed Eckert George J. Sawada Stephen

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.9, Iss.4, 2009-08, pp. : 231-240

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pediatric Heart Failure Therapy with β-Adrenoceptor Antagonists

By Foerster Susan R. Canter Charles E.

Pediatric Drugs, Vol. 10, Iss. 2, 2008-01 ,pp. : 125-134

Adis International

Access to resources Recommend Favorite

β-Adrenoceptor Antagonists in Elderly Patients with Heart Failure: A Critical Review of Their Efficacy and Tolerability

By Dobre Daniela

Drugs & Aging, Vol. 24, Iss. 12, 2007-01 ,pp. : 1031-1044

Adis International

Access to resources Recommend Favorite

β-Adrenoceptor Antagonists in Elderly Patients with Chronic Heart Failure: Therapeutic Potential of Third-Generation Agents

By Coats Andrew J.S.

Drugs & Aging, Vol. 23, Iss. 2, 2006-01 ,pp. : 93-99

Adis International

Access to resources Recommend Favorite

Evolving Concepts Concerning Cardiac &bgr;-Adrenoceptor Function in Heart Failure

Current Pharmaceutical Design, Vol. 16, Iss. 37, 2010-12 ,pp. : 4148-4158

Bentham Science Publishers

Access to resources Recommend Favorite

β-adrenoceptor blocker treatment and the cardiac β-adrenoceptor-G-protein(s)-adenylyl cyclase system in chronic heart failure

By Brodde Otto-Erich

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 374, Iss. 5-6, 2007-02 ,pp. : 361-372

Springer Publishing Company

Access to resources Recommend Favorite